Literature DB >> 23653407

Prophylaxis of venous thromboembolism in elderly patients with multimorbidity.

Maura Marcucci1, Alfonso Iorio, Alessandro Nobili, Mauro Tettamanti, Luca Pasina, Codjo Djignefa Djade, Alessandra Marengoni, Francesco Salerno, Salvatore Corrao, Pier Mannuccio Mannucci.   

Abstract

Pharmacological thromboprophylaxis (TP) is known to reduce venous thromboembolism (VTE) in medical inpatients, but the criteria for risk-driven prescription, safety and impact on mortality are still debated. We analyze data on elderly patients with multimorbidities admitted in the year 2010 to the Italian internal medicine wards participating in the REPOSI registry to investigate the rate of TP during the hospital stay, and analyze the factors that are related to its prescription. Multivariate logistic regression, area under the ROC curve and CART analysis were performed to look for independent predictors of TP prescription. Association between TP and VTE, bleeding and death in hospital and during the 3-month post-discharge follow-up were explored by logistic regression and propensity score analysis. Among the 1,380 patients enrolled, 171 (15.2 %) were on TP during the hospital stay (162 on low molecular weight heparins, 9 on fondaparinux). The disability Barthel index was the main independent predictor of TP prescription. Rate of fatal and non-fatal VTE and bleeding during and after hospitalization did not differ between TP and non-TP patients. In-hospital and post-discharge mortality was significantly higher in patients on TP, that however was not an independent predictor of mortality. Among elderly medical patients there was a relatively low rate of TP, that was more frequently prescribed to patients with a higher degree of disability and who had an overall higher mortality.

Entities:  

Mesh:

Year:  2013        PMID: 23653407     DOI: 10.1007/s11739-013-0944-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  34 in total

1.  Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.

Authors:  Hervé Decousus; Victor F Tapson; Jean-François Bergmann; Beng H Chong; James B Froehlich; Ajay K Kakkar; Geno J Merli; Manuel Monreal; Mashio Nakamura; Ricardo Pavanello; Mario Pini; Franco Piovella; Frederick A Spencer; Alex C Spyropoulos; Alexander G G Turpie; Rainer B Zotz; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2010-05-07       Impact factor: 9.410

2.  Identifying acutely ill medical patients requiring thromboprophylaxis.

Authors:  P Chopard; D Spirk; H Bounameaux
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

3.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

4.  Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we over-treating our patients?

Authors:  Moshe Vardi; Michal Haran
Journal:  Eur J Intern Med       Date:  2011-12-16       Impact factor: 4.487

5.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

6.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

7.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Venous thromboembolism in nonagenarians. Findings from the RIETE Registry.

Authors:  Beatriz Vasco; Joan Carles Villalba; Luciano Lopez-Jimenez; Conxita Falga; Julio Montes; Javier Trujillo-Santos; Manuel Monreal
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

9.  Deep-vein thrombosis in the elderly.

Authors:  Gregory Piazza; Ali Seddighzadeh; Samuel Z Goldhaber
Journal:  Clin Appl Thromb Hemost       Date:  2008-07-01       Impact factor: 2.389

10.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

View more
  9 in total

1.  Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall?

Authors:  Francesco Violi; Ludovica Perri; Lorenzo Loffredo
Journal:  Intern Emerg Med       Date:  2013-06-16       Impact factor: 3.397

2.  Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data.

Authors:  Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2014-10-11       Impact factor: 3.397

3.  Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.

Authors:  Antonella Tufano; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2018-03-14       Impact factor: 3.397

4.  Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).

Authors:  Luca Depietri; Marco Marietta; Stefania Scarlini; Matteo Marcacci; Elena Corradini; Antonello Pietrangelo; Paolo Ventura
Journal:  Intern Emerg Med       Date:  2018-03-03       Impact factor: 3.397

Review 5.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

6.  Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients.

Authors:  Raffaella Rossio; Sara Mandelli; Ilaria Ardoino; Alessandro Nobili; Flora Peyvandi; Pier Mannuccio Mannucci; Carlotta Franchi
Journal:  Intern Emerg Med       Date:  2022-10-14       Impact factor: 5.472

Review 7.  Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

8.  Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults.

Authors:  Juliessa M Pavon; Richard J Sloane; Carl F Pieper; Cathleen S Colón-Emeric; Harvey J Cohen; David Gallagher; Miriam C Morey; Midori McCarty; Thomas L Ortel; Susan N Hastings
Journal:  Appl Clin Inform       Date:  2018-09-26       Impact factor: 2.342

9.  The adherence to initial processes of care in elderly patients with acute venous thromboembolism.

Authors:  Anna K Stuck; Marie Méan; Andreas Limacher; Marc Righini; Kurt Jaeger; Hans-Jürg Beer; Joseph Osterwalder; Beat Frauchiger; Christian M Matter; Nils Kucher; Michael Egloff; Markus Aschwanden; Marc Husmann; Anne Angelillo-Scherrer; Nicolas Rodondi; Drahomir Aujesky
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.